Long-term direct costs before and after proctocolectomy for ulcerative colitis: A population-based study in olmsted county, Minnesota

Diseases of the Colon and Rectum

Volumn 52, Issue 11, 2009, Pages 1815-1823

  Holubar, Stefan D ^a   Long, Kirsten Hall ^a   Loftus, Edward V ^a   Wolff, Bruce G ^a   Pemberton, John H ^a   Cima, Robert R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cost analysis; Epidemiology; Ileal pouch anal anastomosis; Population based; Proctocolectomy; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; BOOTSTRAPPING; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; COST BENEFIT ANALYSIS; DATA BASE; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROCTOCOLECTOMY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; ULCERATIVE COLITIS; UNITED STATES; CHRONIC DISEASE; CONFIDENCE INTERVAL; ECONOMICS; MIDDLE AGED; NONPARAMETRIC TEST;

ADULT; CHRONIC DISEASE; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PROCTOCOLECTOMY, RESTORATIVE; STATISTICS, NONPARAMETRIC;

EID: 75349110909     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3181b327a6     Document Type: Article

References (42)

1. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008;135:1907-13.
2. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-61.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-9.
4. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12:402-12.
5. Irvine EJ. Quality oflife ofpatients with ulcerative colitis: past, present, and future. Inflamm Bowel Dis 2008;14:554-65.
6. Pemberton JH. Surgery for ulcerative colitis. Surg Clin North Am 1987;67:633-50.
7. Holubar S, Hyman N. Continence alterations after ileal pouchanal anastomosis do not diminish quality of life. Dis Colon Rectum 2003;46:1489-91.
8. Larson DW, Davies MM, Dozois EJ, et al. Sexual function, body image, and quality of life after laparoscopic and open ileal pouchanal anastomosis. Dis Colon Rectum 2008;51:392-6.
9. Arseneau KO, Sultan S, Provenzale DT, et al. Do patient preferences influence decisions on treatment for patients with steroidrefractory ulcerative colitis? Clin Gastroenterol Hepatol 2006;4: 1135-42.
10. Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA. Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005;100:1357-61.
11. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology 2007;133:1779-86.
12. Roberts SE, Williams JG, Yeates D, Goldacre MJ. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies. BMJ 2007;335:1033.
13. Holubar SD, Cima RR, Pemberton JH. Does infliximab increase complications after surgery for inflammatory bowel disease? F1000 Med Rep 2008;1:10 at http://f1000medicine.com/reports/10.3410/m1-10/article-short.html
14. Selvasekar CR, Cima RR, Larson DW, et al. Effect ofinfliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007;204:956-63.
15. Mor IJ, Vogel JD, da Luz Moreira A, Shen B, Hammel J, Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008;51:1202-10.
16. Schluender SJ, Ippoliti A, Dubinsky M, et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007;50: 1747-53.
17. Swenson BR, Hollenbeak CS, Koltun WA. Hospital costs and risk factors associated with complications of the ileal pouch anal anastomosis. Surgery 2002;132:767-74.
18. Swenson BR, Hollenbeak CS, Koltun WA. Factors affecting cost and length of stay associated with the ileal pouchanal anastomosis. Dis Colon Rectum 2003;46:754-61.
19. Swenson BR, Hollenbeak CS, Poritz LS, Koltun WA. Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. Dis Colon Rectum 2005;48: 256-61.
20. Sher ME, Weiss EG, Nogueras JJ, Wexner SD. Morbidity of medical therapy for ulcerative colitis: what are we really saving? Int J Colorectal Dis 1996;11:287-93.
21. Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 2006;101:110-8.
22. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
23. Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998; 18:S39-56.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240: 205-13.
26. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-40.
27. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76. (Pubitemid 41770166)
28. Lim M, Sagar P, Abdulgader A, Thekkinkattil D, Burke D. The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouchanal anastomosis. Dis Colon Rectum 2007;50:943-51.
29. Heuschen UA, Hinz U, Allemeyer EH, et al. Risk factors for ileoanal J pouchrelated septic complications in ulcerative colitis and familial adenomatous polyposis. Ann Surg 2002;235: 207-16.
30. Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309-17.
31. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004;53:1471-8.
32. Odes S, Vardi H, Friger M, et al. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006;131:719-28.
33. Stark R, Konig HH, Leidl R. Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 2006;24:797-814.
34. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med 2008;50:1261-72.
35. Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000;95:677-83.
36. Holubar SD, Larson DW, Dozois EJ, Pattana-Arun J, Pemberton JH, Cima RR. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum 2009;52:187-92.
37. Sandborn W, Rutgeerts P, Feagan BG, et al. Infliximab reduces colectomy in patients with moderate-to-severe ulcerative colitis: analysis from ACT 1 and ACT 2 [abstract]. Am J Gastroenterol 2007;102(suppl):S479.
38. Larson DW, Cima RR, Dozois EJ, et al. Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience. Ann Surg 2006;243:667-72.
39. Holubar SD, Privitera A, Cima RR, Dozois EJ, Pemberton JH, Larson DW. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis 2009 Mar 5. [Epub ahead of print]
40. Hayes JL, Hansen P. Is laparoscopic colectomy for cancer cost- effective relative to open colectomy? ANZ J Surg 2007;77:782-6.
41. Ridgway PF, Boyle E, Keane FB, Neary P. Laparoscopic colectomy is cheaper than conventional open resection. Colorectal Dis 2007;9:819-24.
42. Koopmann MC, Harms BA, Heise CP. Money well spent: a comparison of hospital operating margin for laparoscopic and open colectomies. Surgery 2007;142:546-55.